CYAXXVI
Live / Applied — Second extension granted (statement of use) (as of 29 Dec 2025)
What this means for you
Not registered yet, but its 29 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98381209
- Mark type
- Stylized text
- Filed
- 29 Jan 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Brandon P. Leahy
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing heart disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement
Owner
- Renibus Therapeutics, Inc., Southlake, TX, US
- Renibus Therapeutics, Inc., Southlake, TX, US
Prosecution history
- 30 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Dec 2025 — SOU EXTENSION 2 GRANTED
- 29 Dec 2025 — SOU EXTENSION 2 FILED
- 29 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jun 2025 — SOU EXTENSION 1 GRANTED
- 06 Jun 2025 — SOU EXTENSION 1 FILED
- 06 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION
- 20 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE